Halozyme Therapeutics shares owned by Verity Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Verity Asset Management
from 13F filings
Historical chart of Verity Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Verity Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Verity Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.5M | 48k | 73.34 |
| 2025-06-30 | $2.3M | 44k | 52.02 |
| 2025-03-31 | $2.7M | 42k | 63.81 |
| 2024-12-31 | $2.2M | 46k | 47.81 |
| 2024-09-30 | $2.2M | 38k | 57.24 |
| 2024-06-30 | $2.1M | 41k | 52.36 |
| 2024-03-31 | $1.6M | 39k | 40.68 |
| 2023-12-31 | $1.1M | 29k | 36.96 |
| 2023-09-30 | $1.2M | 31k | 38.20 |
| 2023-06-30 | $922k | 26k | 36.07 |
| 2023-03-31 | $1.2M | 31k | 38.19 |
| 2022-12-31 | $1.5M | 27k | 56.90 |
| 2022-09-30 | $1.3M | 32k | 39.54 |
| 2022-03-31 | $1.2M | 31k | 39.91 |
| 2021-12-31 | $1.4M | 36k | 40.20 |
| 2021-09-30 | $1.2M | 30k | 40.67 |
| 2021-06-30 | $1.0M | 22k | 45.40 |
| 2021-03-31 | $805k | 19k | 41.69 |
| 2020-12-31 | $793k | 19k | 42.69 |
| 2020-09-30 | $519k | 20k | 26.29 |
| 2020-06-30 | $593k | 22k | 26.83 |
| 2020-03-31 | $429k | 24k | 17.99 |
| 2019-12-31 | $527k | 30k | 17.72 |
| 2019-09-30 | $479k | 31k | 15.52 |
| 2019-06-30 | $538k | 31k | 17.17 |
| 2019-03-31 | $347k | 22k | 16.09 |
| 2018-12-31 | $297k | 20k | 14.62 |
| 2014-12-31 | $157k | 16k | 9.63 |